Gene Therapy: Advances in Delivery Systems, Genome Editing Technologies, and Applications in Human and Veterinary Medicine

基因组编辑 遗传增强 清脆的 基因传递 生物安全 计算生物学 转导(生物物理学) 病毒载体 生物 基因 载体(分子生物学) 生物信息学 基因组 遗传性疾病 生物技术 疾病 医学 人类基因组 基因组工程 精密医学 个性化医疗 疾病预防 人类遗传学 良好制造规范 人类疾病 Cas9 电穿孔 转化医学 基因组学
作者
Deepak Chandran,Ramanathan Appanasamy,Pran Mohankumar,K S Sreyass,Lejaniya Abdul Kalam Saleena
出处
期刊:Current Gene Therapy [Bentham Science Publishers]
卷期号:26
标识
DOI:10.2174/0115665232527300261105051202
摘要

Gene therapy has emerged as a revolutionary therapeutic strategy for the treatment of inherited, acquired, and age-related diseases through the modification, replacement, or correction of defective genes. Advances in molecular biology, viral engineering, and genome-editing technologies have significantly enhanced the efficiency and safety of gene delivery systems. This review provides a comprehensive overview of gene therapy, including its classification, delivery methods, and therapeutic applications in both human and veterinary medicine. Viral vectors such as adenoviral, retroviral, lentiviral, adeno-associated viral, and poxviral vectors remain the most effective delivery platforms owing to their high transduction efficiency, whereas non-viral approaches including physical and chemical delivery systems offer improved biosafety and reduced immunogenicity. Recent developments in gene-editing technologies, particularly clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein systems, have expanded the therapeutic potential of gene therapy by enabling precise genome modifications. The review highlights the successful application of gene therapy in treating genetic disorders, cancer gene therapy, retinal diseases, neuromuscular disorders, hemophilia, and metabolic diseases in humans, as well as inherited and acquired diseases in companion and livestock animals. Despite remarkable progress, challenges related to delivery efficiency, immune responses, off-target effects, manufacturing scalability, regulatory approval, and long-term safety continue to limit widespread clinical implementation. Advances in vector design, genome-editing precision, artificial intelligence-assisted development, and regulatory frameworks are expected to address these limitations. Overall, gene therapy and CRISPRbased technologies represent promising platforms for the development of next-generation precision medicines that could transform disease management in both human and veterinary healthcare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZY完成签到 ,获得积分10
1秒前
天天向上的应助被时平谊采纳,获得10
1秒前
周周发布了新的文献求助50
2秒前
科研通AI6.3的应助被glacier采纳,获得10
2秒前
3秒前
小马甲的应助被薛wen晶采纳,获得10
3秒前
hurys发布了新的文献求助10
4秒前
6秒前
6秒前
syvshc的应助被赵晶晶采纳,获得10
7秒前
大胆的路灯完成签到,获得积分10
7秒前
馍馍发布了新的文献求助30
8秒前
Lee完成签到,获得积分10
8秒前
影zi完成签到 ,获得积分10
10秒前
11秒前
12秒前
theinu完成签到,获得积分10
12秒前
wwwwwwwwww完成签到,获得积分10
12秒前
12秒前
眯眯眼的芷波完成签到,获得积分20
13秒前
13秒前
efwefw完成签到,获得积分10
14秒前
14秒前
Wanfeng完成签到,获得积分10
14秒前
咕噜咕噜完成签到,获得积分10
14秒前
14秒前
传奇3的应助被雯雯采纳,获得10
15秒前
cxy完成签到 ,获得积分10
15秒前
Owen的应助被左贵辉采纳,获得10
15秒前
彭佳丽完成签到,获得积分10
15秒前
16秒前
Orange的应助被周周采纳,获得10
17秒前
李麟发布了新的文献求助10
17秒前
17秒前
18秒前
hurys完成签到,获得积分10
18秒前
研友_VZG7GZ的应助被坚定啤酒采纳,获得10
18秒前
李健的应助被无心的可仁采纳,获得10
18秒前
123发布了新的文献求助10
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186676
求助须知:如何正确求助?哪些是违规求助? 9574945
关于积分的说明 21839037
捐赠科研通 7784275
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559187
邀请新用户注册赠送积分活动 2481611